The prevalence of insulin resistance in polycystic ovarian syndrome cases at a tertiary care hospital: a cross sectional study

Rama D. Borse; Nidhi S. Kurkal; Aditi H. Abhade

doi:10.18203/2320-1770.ijrcog20221681

Authors

Rama D. Borse Consultant, Kadam Hospital, Nanded
Nidhi S. Kurkal Assistant Professor, GGMC and JJ Group of Hospitals, Mumbai, Maharashtra, India
Aditi H. Abhade Junior Consultant, JK Women Hospital, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20221681

Keywords:

PCOs, Insulin resistance, Metabolic syndrome, infertility, BMI

Abstract

Background: Insulin resistance (IR) is defined clinically as the inability of a known quantity of exogenous or endogenous insulin to increase glucose uptake and utilization in an individual as much as it does in a normal population PCOS is a disease of heterogeneous disturbance of reproductive, endocrine and metabolic functions. The objective of the study was to study the prevalence of insulin resistance in polycystic ovarian syndrome cases.

Methods: The present cross sectional study was carried out at Obstetrics and Gynecology department, MGM medical college, Kalamboli, Navi Mumbai for a period of 2 years from 2011 to 2013 on total of 50 women aged between 16-39 years, coming to OPD with complaints of menstrual irregularities, infertility or hirsutism. After initial assessment, pelvic ultrasonography was done in these women to confirm the diagnosis of polycystic ovaries.

Results: Majority 26 (52%) cases were in age group of 16-25 years and, majority 19 (38%) cases were in overweight (25-29.99) group. There were 21 (42%) women with insulin resistance When chi square test was applied to assess the association between BMI and insulin resistance, it was found to be statistically significant. (p=0.01).

Conclusions: The prevalence of abnormal glucose tolerance, dyslipidemia, insulin resistance and metabolic syndrome was observed to be high in PCOS. We conclude that physician should consider that early recognition to reduce the incidence and severity of associated potential sequelae.

Metrics

Metrics Loading ...

References

Cioana M, Deng J, Nadarajah A, Hou M, Qiu Y, Chen S, et al. Prevalence of Polycystic Ovary Syndrome in Patients With Pediatric Type 2 Diabetes. JAMA Network Open. 2022;5(2):e2147454.

Christensen SB, Black MH, Smith N. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril. 2013;100(2):470-7.

Naz MSG, Tehrani FR, Majd HA. The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis. Int J Reprod Biomed. 2019;17(8):533-42.

Fauser BCJM, Tarlatzis BC, Rebar RW. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28-38.e25.

Ibáñez L, Oberfield SE, Witchel S. An international consortium update:pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. 2017;88(6):371-95.

Legro RS, Arslanian SA, Ehrmann DA. Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-92.

Witchel SF, Oberfield S, Rosenfield RL. The diagnosis of polycystic ovary syndrome during adolescence.Horm Res Paediatr. 2015; 83:376-89.

Peña AS, Witchel SF, Hoeger KM. Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. 2020;18(1):72.

Tay CT, Hart RJ, Hickey M. Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood. BMC Med. 2020;18(1):389.

Baillargeon JP, Iuorno MJ, Nestler JE. Insulin sensitizers for polycystic ovary syndrome. Clin Obstet Gynecol.2003;46(2):325-40.

Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981-1030.

Wang R, Mol B. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?. Human Reproduction. 2016;32(2):261-4.

Madusudhanan RR, Nambisan B, Brahmanandan M, Radha S. Study on the Prevalence and Characteristics of Metabolic Syndrome in Women of Reproductive Age Group with Polycystic Ovarian Syndrome. J South Asian Feder Obst Gynae. 2017;9(4):341-7.

Iftikhar S, Collazo-Clavell ML, Roger VL, St Sauver J, Brown RD Jr, Cha S et al. Risk of cardiovascular events in patients with polycystic ovary syndrome. Neth J Med. 2012;70(2):74-80.

Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219-31.

Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocr Metab. 2014;18(31):7-24.

Balaji S, Amadi C, Prasad S, Kasav J, Upadhyay V, Singh AK, et al. Urban rural comparisons of polycystic ovary syndrome burden among adolescent girls in a hospital setting in India. Biomed Res Int. 2015;15(89):1-10.

Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22(1):141-6.

Mandrelle K, Kamath MS, Bondu DJ, Chandy A, Aleyamma T, George K. Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India. J Hum Reprod Sci. 2012;5(1):26-31.

Al-Jefout M, Alnawaiseh N, Al-Qtaitat A. Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes. Sci Rep. 2017;7:5339.

Roya R, Akbar A, Wajeeda T, Avinash B, Humaira M. An Indian Evidence-Based Study of Prevalence, phenotypic features, lifestyle modifications of Polycystic Ovarian Syndrome Patients. J Gynecol Women’s Health. 2021;21(4):556069.